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Abstract 
Introduction: Obesity is often accompanied by low-grade inflammation. In recent years a few blood-based inflammatory markers 
— neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-
to-monocyte ratio (LMR), and monocyte-to-high-density lipoprotein ratio (MHR) — have been identified. They have been proven to 
correlate well with established inflammatory markers such as hsCRP and have a prognostic value among others in patients with coronary 
artery disease, heart failure, and malignancies. The aim of the study was to find markers associated with obesity in young heathy adults.
Material and methods: The study group included 321 young healthy adults aged 18-35 years (210 males and 111 females). Partial least 
squares regression analysis was used to find variables associated with body mass index (BMI). Analysed variables included complete blood 
count, lipid profile, sex hormone levels, acute-phase protein levels, and blood-based inflammatory markers.
Results: Variables with the strongest association with BMI in the group of men were HDL% and apolipoprotein B, and in the group of wo-
men, HDL, HDL%, triglycerides, and MHR. Novel inflammatory markers were not associated with BMI, except MHR. We found significant 
(p < 0.001) correlations between novel biomarkers (NLR, dNLR) and hsCRP and fibrinogen levels in the group of subjects with obesity.
Conclusions: Blood-based inflammatory markers significantly correlate with hsCRP and fibrinogen in young healthy adults with obesity, 
which may reflect the subclinical inflammation in this group of individuals. (Endokrynol Pol 2019; 70 (2): 135–142)
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Introduction 
Overweight and obesity are becoming more frequent 
in the population of young adults. Although mortality 
rates in this cohort are low, the presence of overweight 
and obesity during this period may significantly in-
crease the risk of chronic diseases later in life [1, 2] and 
have socio-economic consequences [3]. The develop-
ment of obesity is affected by many factors including 
behavioural, environmental, and genetic factors [2, 4, 
5]. In a small percentage of cases, obesity is caused by 
endocrine disorders. On the other hand, in individuals 
with excessive body weight, cytokines, inflammatory 
factors, and adipokines, secreted by adipose tissue 
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normal body mass group (BMI 18.5–25.0 kg/m2); overweight (BMI 
between ≥ 25.0, < 30.0 kg/m2); and obesity group (BMI ≥ 30.0 kg/m2). 
Underweight individuals (BMI < 18.5 kg/m2) were excluded from 
this analysis.
Blood samples
In each patient, blood was collected between 7 a.m. and 9 a.m., ap-
proximately 8–10 h after the last meal. Complete blood count (CBC) 
was performed on a Sysmex XE2100 (Sysmex Corporation, Kobe, 
Japan), and biochemical parameters were assessed with a Cobas 
6000 (Roche Diagnostics, Indianapolis, IN, USA) using Roche re-
agents. We determined CBC, the level of fibrinogen, ceruloplasmin, 
aspartate aminotransferase (AST), alanine aminotransferase (ALT), 
gamma-glutamyltransferase (GGT), bilirubin, alkaline phosphatase 
(ALP), total protein, lipid profile, apolipoprotein A1, apolipoprotein 
B, homocysteine, cystatin C, vitamin D, glucose, lactate dehydroge-
nase (LDH), haemoglobin A1c (HbA1c), creatinine, uric acid, sodium, 
potassium, calcium, phosphorus, and high-sensitivity C-reactive 
protein (hsCRP). In addition, we determined the following hor-
mones: thyroid-stimulating hormone (TSH), follicle-stimulating 
hormone (FSH), luteinising hormone (LH), oestradiol, progester-
one, total testosterone, free testosterone, and sex hormone binding 
protein (SHBG).
CBC-based inflammatory markers
Based on CBC parameters and HDL (high-density lipoprotein) 
level, we also calculated factors that were reported to correlate well 
with markers of inflammation: NLR, PLR, LMR, dNLR (calculated 
by dividing the neutrophil count by the difference between leuko-
cytes and neutrophil counts), and MHR [14].
Statistical analysis
Values of continuous and dichotomous variables concerning 
clinical characteristics between groups of individuals with 
normal body weight, overweight, and obesity were compared 
with appropriate tests for trends — Jonckheere-Terpstra and 
Cochrane-Armitage tests. To evaluate the relationship between 
biomarkers and BMI, considering the large number of analysed 
variables and the co-linearity of some of the variables analysed, 
we used partial least squares regression (PLSR). First, because the 
normality assumption for analysed biomarker concentrations was 
not fulfilled in either the group of women or men, concentrations 
were log-transformed. Reassessment of normality of distribution 
did not show significant deviations from normal distribution. 
Second, the variables were mean-centred and divided by stan-
dard deviation. PLSR analysis, which we applied in this study, 
relies on a transformation of 57 analysed independent variables 
(log-transformed biomarker concentrations) into latent factors 
that describe maximum correlation between analysed variables 
and the dependent variable (BMI). Each of these latent factors 
is a pattern of biomarkers that has an association with BMI. The 
influence of biomarkers on a latent factor, and consequently their 
relationship with BMI, is reflected by factor loadings. The higher 
the loading, the stronger this relationship [22]. In addition, we 
performed a univariate regression analysis of the association of 
analysed variables with BMI. Additionally, we analysed correla-
tions between novel blood-based inflammatory biomarkers and 
well-established inflammatory biomarkers (hsCRP, fibrinogen) 
across BMI categories (normal body weight, overweight, and 
obesity). Due to the large number of these analyses, a correc-
tion was made for multiple comparisons. Statistically significant 
results where those for which the false discovery rate (FDR) was 
less than 0.05.
The study conformed to the Declaration of Helsinki and was 
approved by the Ethics Committee of the Institute of Occupa-
tional Medicine and Environmental Health, Sosnowiec, Poland. 
Informed, written consent was obtained from all subjects enrolled 
in the study.
and developing insulin resistance, are responsible for 
systemic and hormonal axis dysregulation, i.e. the sex 
hormone system, thyroid gland function, and vita-
min D homeostasis [6]. However, not all patients who 
are overweight or obese experience such complica-
tions. For these reasons, one of the important primary 
prevention tools for obesity-related illnesses would be 
the ability to identify patients at high risk of developing 
obesity-related diseases as opposed to people referred 
to as “metabolically healthy obese” [7, 8]. 
The subclinical inflammation accompanying over-
weight and obesity may be a factor that identifies 
patients at risk of developing obesity complications 
because inflammation plays a major role in the de-
velopment of insulin resistance and cardiometabolic 
complications [9]. In addition to commonly known 
C-reactive protein (CRP) and fibrinogen, interleukin-6 
(IL-6) and tumour necrosis factor alpha (TNF-a) have 
also been found to be associated with obesity [9]. 
However, these markers are not readily obtainable in 
everyday clinical practice. Therefore, it is necessary 
to search for cheaper and more accessible biomarkers 
of inflammation related to body mass index (BMI). 
Several recent studies have drawn attention to easily 
available blood-based inflammatory markers [10, 11]. 
Relationships between neutrophil to lymphocyte ra-
tio (NLR) [10–15], derived neutrophil to lymphocyte 
ratio (dNLR) [10], platelet to lymphocyte ratio (PLR) 
[16], lymphocyte to monocyte ratio (LMR) [12, 14, 17], 
monocyte to high-density lipoprotein ratio (MHR) [18, 
19], inflammation, and prognosis in cardiovascular 
diseases and cancer have all been reported. The as-
sociation of these inflammatory parameters with BMI 
remains unclear. The aim of our study was to find 
biomarkers associated with obesity in the group of 
young heathy adults.
Material and methods 
Study group
The study group consisted of individuals aged 18-35 years from 
the MAGNETIC (Metabolic And GeNETic Profiling of Young 
Adults with and without a Family History of Premature Coronary 
Heart Disease) project, who were healthy descendants of patients 
hospitalised in the Silesian Centre for Heart Diseases because of 
premature coronary artery disease (myocardial infarction or angio-
graphically confirmed stable coronary artery disease that occurred 
before age 55 years in men and before 65 years in women) [20, 21]. 
The study flow chart is shown in Figure 1. The exclusion criteria 
included use of medicines (including contraceptives in women), 
chronic conditions, acute infections, pregnancy, and lactation. All 
women were recruited during menstrual bleeding. Blood pressure 
was measured in each patient at the time of enrolment. Detailed 
information on family history of neoplasm, cardiovascular, gastro-
intestinal, haematological, metabolic, nephrological, rheumatic, 
and allergic diseases was also collected. 
The subjects were divided into three groups according to value 
of body mass index (BMI) (body mass [kg] / body height [m]2): 
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Characteristics of the study group
Baseline characteristics of the study group are shown in 
Table I. Subjects with obesity, compared to those with 
overweight and normal weight, were older and more 
frequently male. There was also a significant trend 
among groups associated with lower physical activ-
ity and higher alcohol consumption, as well as with 
higher blood pressure in groups with overweight and 
obesity. The percentage of subjects with higher educa-
tion was lower in the group with obesity. There was no 
significant relationship between subjects with normal 
body weight, overweight, and obesity in terms of sleep 
duration and smoking.
Relationship between analysed parameters 
and BMI
The results of the PLSR analysis indicate that the most 
significant contributors to differentiation of people with 
normal body weight and with obesity in the group of men 
were HDL% and apolipoprotein B, and in the group of 
women, HDL, HDL%, MHR, and triglycerides (Tab. II). In 
both the female and male groups, separation of individu-
als with normal body weight and with obesity proceeded 
along first latent factor or along the horizontal axis in 
Figures 2A and 2B. The differentiation of individuals in 
terms of BMI values in both men and women were not 
influenced by blood-based inflammatory biomarkers, ex-
cept MHR. Additionally, univariate analysis of correlation 
between analysed variables and BMI, similar to the PLSR 
analysis results, showed that inflammatory, hormonal, 
and lipid parameters had the strongest association with 
BMI. Correlations with BMI related to blood-based inflam-
matory markers, except for MHR, were weak and, after 
adjustment for multiple intergroup comparisons, were 
insignificant (NLR, dNLR, LMR) or borderline significant 
(PLR in group of men) (Tab. III and IV).
CBC parameters in terms of BMI 
The number of leukocytes, monocytes, lymphocytes, 
and neutrophils were higher in the overweight and 
Number of subjects  
(premature CAD patients' offspring)  
whom we managed to contact — 1345
Number of subjects who applied for pre-
recruitment interview — 374
Number of subjects recruited — 347
Number of subjects included  
in the analysis — 321
Males  
N = 210
Individuals excluded due to:
• not meeting the age enrollment criteria (266)
• chronic diseases/medication intake (374)
• pregnancy and postpartum period (19)




Individuals excluded due to:
Chronic diseases/medication intake:
• bipolar affective disorder (1)
• asthma (3)
• celiac disease (1)
• Crohn's disease (1)
• diabetes mellitus type 2 (1)
• hypertension (1)
• gastroesophageal reflux disease (2)
• Marfan syndrome (1)
• paroxymal tachycardia (1)
• hypothyroidism (3)
• in vitro therapy (1)
• hepatic steatosis in treatment (1)
• other (10)
Individuals excluded due to:
• abnormal level of TSH > 5.5 mU/L (6)
• CRP > 10 mg/dL (6)
• underweight (10)
• oral contraceptive use (4)
Figure 1. Flow chart of study population. CAD — coronary artery disease; CRP — C-reactive protein
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obesity groups compared with the group with normal 
body weight, while there was no association between 
platelet levels and BMI categories (Fig. 3). 
Correlation between hsCRP and blood-based 
inflammatory markers
The correlation between hsCRP and levels of 
blood-based inflammatory markers was insignificant 
or weak in the groups with normal body weight and 
overweight; however, the correlation of blood-based 
inflammatory markers (NLR, dNLR) and hsCRP and 
fibrinogen was highly significant in the group of indi-
viduals with obesity (Tab. V). 
Discussion
The results of recent studies have highlighted the 
special role of low-level chronic inflammation, which 
accompanies obesity in the development of insulin 
resistance and consequently contributes to the devel-
opment of metabolic syndrome [23–26]. Excessive food 
consumption leads to numerous changes in intracel-
lular metabolism, mainly in adipose tissue but also 
in tissues of other organs such as liver, pancreas, and 
muscles [27]. This results in inflammatory responses 
and release of proinflammatory cytokines (TNF-a, 
IL-6, interleukin-1b, and others) [28, 29]. In addition, 
inflammatory cells, mainly macrophages, which also 
play an important role in the inflammatory response, 
infiltrate the adipose tissue. Secretion of mediators of 
the inflammatory response leads to increased produc-
tion of acute-phase proteins [27, 28]. 
Numerous studies have shown that inflammation 
is associated with an increased number of neutrophils, 
while lymphocytopaenia is a common response to 
physiological stress [14, 15, 30]. In pathologic conditions 
Table II. Factor loadings for latent factor 1 in male and 
female groups
Male group Female group
Variable Latent factor 1 Variable
Latent 
factor 1
Apolipoprotein B 0.27 MHR 0.27
Triglycerides 0.26 Triglycerides 0.27
LDL 0.25 Fibrinogen 0.24
Total cholesterol 0.24 Free testosterone 0.23
GGT 0.23 hsCRP 0.23
MHR 0.23 Uric acid 0.22
ALT 0.22 ALP 0.21
Uric Acid 0.2 ALT 0.21
WBC 0.18 Apolipoprotein B 0.20
Fibrinogen 0.18 GGT 0.19
HDL –0.20 Apolipoprotein A1 –0.16
Testosterone –0.22 SHBG –0.21
SHBG –0.23 HDL –0.28
HDL (%) –0.29 HDL (%) –0.29
Factor loadings for latent factor 1 in male and female groups are shown in 
the above table. The higher the absolute value of the factor loading of a given 
variable for a given latent factor, the greater the influence of this variable on the 
determination of the score for a latent factor for a particular observation.  
LDL — low-density lipoprotein; GGT — gamma-glutamyltransferase;  
MHR — monocyte to high-density lipoprotein ratio; ALT — alanine 
aminotransferase; WBC — white blood cells; HDL — high-density lipoprotein; 
SHBG — sex hormone binding globulin; ALP — alkaline phosphatase;  
hsCRP — high-sensitivity C-reactive protein
Table I. Baseline characteristics of the study population
Variables Individuals with normal body weight (n = 158)
Overweight individuals  
(n = 112)




Age (years) 28.0 (24.0–32.4) 29.7 (26.2–33.0) 31.4 (27.8–33.4) 0.003
Sex (male) 84 (53.2) 90 (80.4) 36 (70.6) < 0.0001
Higher education 91 (57.6) 62 (55.4) 19 (37.3) 0.04
Low physical activity level 31 (19.4) 30 (26.6) 22 (42.3) 0.005
Less than six hours of sleep per night 
during weekdays
58 (36.7) 45 (40.2) 20 (39.2) 0.83
Less than six hours of sleep per night 
during the weekends 16 (10.1) 8 (7.1) 3 (5.9) 0.53
Good financial situation 89 (56.3) 60 (53.6) 24 (47.1) 0.51
SBP at the time of recruitment  
[mm Hg]
121 (116–129) 129 (120–138) 132 (125–140) < 0.0001
DBP at the time of recruitment  
[mm Hg]
76 (70–83) 80 (71–85) 82 (75–90) 0.004
Current smoker 37 (23.4) 43 (38.4) 14 (27.5) 0.03
Alcohol [units per week] 2 (1–6) 4 (2–8) 4 (1–9) 0.02
Continuous variables are presented as the median (interquartile range). Categorical variables are presented as the number of patients (percentages)
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where inflammation plays a major role, leukocytosis, 
neutrophilia, and lymphocytopaenia are associ-
ated with worse prognosis [14, 15, 30]. Lymphocytes, 
however, may play an important role in subclinical 
inflammation associated with increased BMI; we 
have shown that lymphocyte count increases across 
BMI categories. As demonstrated in animal models, 
lymphocytes are the first cells of the immune system 
that respond to abnormal adipocyte function associ-
ated with hypertrophy and hypoxia in obesity [31]. 
Lymphocytes then produce inflammatory cytokines, 
which are responsible for monocyte recruitment and 
infiltration of adipose tissue [32]. Perhaps, therefore, 
the inflammatory process associated with initial in-
crease in BMI from normal weight to overweight is 
somewhat different in terms of pathophysiology from 
the inflammatory processes associated with chronic 
diseases, where the increase in neutrophil population 
and the decrease in the lymphocyte population is most 
often observed. This could explain the lack of correla-
tion between hsCRP, fibrinogen, and blood-based in-
flammatory markers in normal weight and overweight 
subjects, and highly significant correlation in obese 
subjects  where an increment in neutrophils is also 
observed. Novel blood-based inflammatory markers 
might expand the armamentarium of inflammatory 
markers that are useful in quantification of subclinical 
inflammatory response in obese patients.
Figure 2AB. A. PLSR scores in the male group. The first two PLSR score-vectors describing the male group. The first component 
explains 12% of X variance and 45% of calibrated Y variance. Patients with lowest to highest BMI can be seen along the first factor. For 
visualisation purposes, patients were grouped into three BMI categories: normal weight (green triangles), overweight (blue squares), 
and obesity (red dots). B. PLSR scores in the female group. The first two PLSR score-vectors describing the female group. The first 
component explains 12% of X variance and 52% of calibrated Y variance. Patients with lowest to highest BMI can be seen along the 
first factor. For visualisation purposes, patients were grouped into three BMI categories: normal weight (green triangles), overweight 
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A potential limitation of the study is that all patients 
had a family history of premature coronary artery 
disease. The strength of our study is the complexity of 
performed biochemical analyses and the homogenous 
group of healthy young adults. Use of the PLSR method 
has allowed simultaneous analysis of collinear variables 
such as HDL%, HDL, apolipoprotein A1, or PLR, NLR, 
and LMR. Another advantage of our research is that all 
women were recruited during menstruation, which 
reduces the impact of hormonal changes associated 
with menstrual cycle.
Conclusions
Blood-based inflammatory markers, i.e. NLR and 
dNLR, significantly correlate with hsCRP and fibrino-
gen in young healthy adults with obesity, which may 
reflect the subclinical inflammation in this group of 
individuals.
Table IV. Univariate correlations with false discovery rate 
(FDR) value < 0.05 between analysed variables and body 
mass index (BMI) in the female group. Correlations are sorted 
according to FDR values from most to least significant.
Variable Correlation Coefficient t-stat p-value FDR
Fibrinogen 0.59 7.63 9.49e–12 2.09E–10
HDL –0.59 –7.6 1.12e–11 2.09E–10
hsCRP 0.58 7.41 2.92e–11 4.09E–10
Triglycerides 0.51 6.11 1.55e–08 1.73E–07
MHR 0.5 6.07 1.91e–08 1.79E–07
HDL% –0.5 –6.0 2.58e–08 2.06E–07
Uric acid 0.47 5.63 1.43e–07 1.00E–06
SHBG –0.44 –5.06 1.69e–06 1.05E–05
Free 
testosterone 0.43 5.01 2.11e–06 1.18E–05
ALT 0.39 4.45 2.11e–05 0.0001
Apolipoprotein 
A1 –0.38 –4.23 4.84e–05 0.0002
ALP 0.39 4.14 6.81e–05 0.0003
Glucose 0.36 4.02 0.0001 0.0004
Phosphate –0.35 –3.91 0.0002 0.0006
GGT 0.3 3.23 0.002 0.006
Lymphocytes 0.28 3.03 0.003 0.01
Cystatin C 0.26 2.83 0.006 0.02
MCV –0.24 –2.58 0.01 0.03
RBC 0.23 2.5 0.01 0.04
HbA1C 0.23 2.45 0.02 0.04
Apolipoprotein 
B 0.23 2.43 0.02 0.04
FDR — false discovery rate; BMI — body mass index; HDL — high-density 
lipoprotein; hsCRP — high-sensitivity C-reactive protein; MHR — monocyte to 
high-density lipoprotein ratio; SHBG — sex hormone binding globulin;  
ALT — alanine aminotransferase; ALP — alkaline phosphatase; GGT — gamma-
glutamyltransferase; LDH — lactate dehydrogenase; RBC — red blood cell;  
MCV — mean corpuscular volume
Table III. Univariate correlations with false discovery rate 
(FDR) value < 0.05 between analysed variables and body 
mass index (BMI) in the male group. Correlations are sorted 
according to FDR values from most to least significant
Variable Correlation Coefficient t–stat p-value FDR
HDL (%) –0.5 –8.28 1.52e–14 4.40e–13
Triglycerides 0.49 8.13 3.89e–14 7.51e–13
GGT 0.42 6.72 1.76e–10 2.55e–09
Apolipoprotein 
B 0.42 6.58 3.70e–10 4.29e–09
SHBG –0.41 –6.53 4.94e–10 4.78e–09
Testosterone –0.41 –6.46 7.18e–10 5.95e–09
ALT 0.41 6.42 8.97e–10 6.50e–09
MHR 0.39 6.06 6.24e–09 4.02e–08
Total 
Cholesterol 0.38 5.86 1.83e–08 1.06e–07
HDL –0.37 –5.76 3.05e–08 1.61e–07
LDL 0.37 5.68 4.54e–08 2.19e–07
hsCRP 0.35 5.32 2.70e–07 1.21e–06
Uric acid 0.32 4.95 1.53e–06 6.36e–06
LDH 0.31 4.64 6.15e–06 2.38e–05
Fibrinogen 0.29 4.34 2.25e–05 8.15e–05
AST 0.28 4.21 3.81e–05 0.0001
Ceruloplasmin 0.27 4.1 5.96e–05 0.0002
WBC 0.26 3.95 0.0001 0.0003
Glucose 0.26 3.89 0.0001 0.0004
Neutrophils 0.23 3.38 0.0009 0.002
Progesterone –0.22 –3.3 0.001 0.003
Phosphate –0.21 –3.09 0.002 0.006
RBC 0.2 2.97 0.003 0.008
Monocytes 0.19 2.72 0.007 0.02
HbA1c 0.18 2.66 0.008 0.02
Haemoglobin 0.18 2.59 0.01 0.02
Lymphocytes 0.18 2.56 0.01 0.02
Albumin –0.17 –2.53 0.01 0.02
PLR –0.16 –2.31 0.02 0.04
FDR — false discovery rate; BMI — body mass index; HDL — high-density 
lipoprotein; GGT — gamma-glutamyltransferase; SHBG — sex hormone 
binding globulin; ALT — alanine aminotransferase; MHR — monocyte to 
high-density lipoprotein ratio; LDL — low-density lipoprotein; hsCRP — high-
sensitivity C-reactive protein; LDH — lactate dehydrogenase; AST — aspartate 
aminotransferase; WBC — white blood cells; RBC — red blood cells;  
PLR — platelet to lymphocyte ratio
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LMR vs.  fibrinogen 0.006 0.94 –0.02 0.77 –0.2 0.15
MHR vs. fibrinogen –0.02 0.8 0.1 0.29 0.1 0.44
NLR — neutrophil to lymphocyte ratio; hsCRP — high sensitivity C-reactive protein; dNLR — derived neutrophil to lymphocyte ratio; PLR — platelet to lymphocyte 
ratio; LMR — lymphocyte to monocyte ratio; MHR — monocyte to high-density lipoprotein ratio
Figure 3. Comparison of lymphocyte (A), neutrophil (B), monocyte (C), white blood cell (WBC) (D), and platelet count (E) between 
groups of normal weight, overweight, and obese subjects
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